These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1448427)

  • 21. Determination of glyceryl trinitrate and its two main metabolites in human plasma using a new sensitive gas chromatography method.
    Ghandforoush-Sattari M; Zakeri-Milani P; Mashayekhi S; Valizadeh H
    Arzneimittelforschung; 2011; 61(3):141-7. PubMed ID: 21528637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of nitroglycerin and its dinitrate metabolites in human plasma by high-performance liquid chromatography with thermal energy analyzer detection.
    Woodward AJ; Lewis PA; Rudman AR; Maddock J
    J Pharm Sci; 1984 Dec; 73(12):1838-40. PubMed ID: 6441842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro.
    Kikkoji T; Gumbleton M; Higo N; Guy RH; Benet LZ
    Pharm Res; 1991 Oct; 8(10):1231-7. PubMed ID: 1796039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent effect of intravenous nitroglycerin on platelet aggregation, and correlation with plasma glyceryl dinitrate concentration in healthy men.
    Karlberg KE; Torfgård K; Ahlner J; Sylvén C
    Am J Cardiol; 1992 Mar; 69(8):802-5. PubMed ID: 1546657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous pharmacodynamic modeling of the non-steady-state effects of three oral doses of 1,3-glyceryl dinitrate upon blood pressure in healthy volunteers.
    Gumbleton M; Benet LZ
    J Pharmacokinet Biopharm; 1993 Oct; 21(5):515-32. PubMed ID: 8145129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
    Jensen KM; Mikkelsen S
    Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of glyceryl trinitrate and its metabolites, 1,2- and 1,3-glyceryl dinitrate, in plasma using capillary gas chromatography.
    Langseth-Manrique K
    J Chromatogr; 1989 Apr; 489(2):462-3. PubMed ID: 2502551
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets.
    Kwon HR; Green P; Curry SH
    Biopharm Drug Dispos; 1992 Mar; 13(2):141-52. PubMed ID: 1550909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous determination of nitroglycerin and its dinitrate metabolites by capillary gas chromatography with electron-capture detection.
    Lee FW; Watari N; Rigod J; Benet LZ
    J Chromatogr; 1988 Apr; 426(2):259-66. PubMed ID: 3134385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of vasodilatory responses to nitroglycerin and its dinitrate metabolites in human veins.
    Haefeli WE; Gumbleton M; Benet LZ; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1992 Dec; 52(6):590-6. PubMed ID: 1458768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Counterregulatory responses: sustained-release isosorbide-5-mononitrate versus transdermal nitroglycerin.
    Parker JD
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):631-8. PubMed ID: 8945675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel pharmacokinetic modelling of transdermal nitroglycerin.
    Auclair B; Sirois G; Ngoc AH; Ducharme MP
    Pharm Res; 1998 Apr; 15(4):614-9. PubMed ID: 9587959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.
    Fox KM; Dargie HJ; Deanfield J; Maseri A
    Br Heart J; 1991 Aug; 66(2):151-5. PubMed ID: 1909152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dose and ointment application technique on nitroglycerin plasma concentrations.
    Iafrate RP; Yost RL; Curry SH; Gotz VP; Caranasos GJ
    Pharmacotherapy; 1983; 3(2 Pt 1):118-24. PubMed ID: 6406987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.
    Jordan RA; Seith L; Henry DA; Wilen MM; Franciosa JA
    Circulation; 1985 May; 71(5):980-6. PubMed ID: 3921279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence evaluation of two glyceryl trinitrate patches after 12-h usage in healthy volunteers.
    Hutt V; Sauter K; Pabst G; Bonn R; Fritschi E
    Arzneimittelforschung; 1994 Dec; 44(12):1313-6. PubMed ID: 7848349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous determination of glyceryl trinitrate and its two dinitrate metabolites in plasma and tissues by capillary gas chromatography.
    Torfgård K; Ahlner J; Norlander B
    J Chromatogr; 1990 Dec; 534():196-201. PubMed ID: 2128838
    [No Abstract]   [Full Text] [Related]  

  • 39. Transdermal nitroglycerin: clinical and pharmacokinetic consequences of renewing the patch and the application site.
    Klemsdal TO; Mundal HH; Bredesen JE; Gjesdal K
    Eur J Clin Pharmacol; 1997; 52(5):379-81. PubMed ID: 9272407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.
    Todd PA; Goa KL; Langtry HD
    Drugs; 1990 Dec; 40(6):880-902. PubMed ID: 2127741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.